Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1975 1
1976 3
1977 1
1978 1
1979 1
1980 1
1981 7
1982 2
1983 1
1984 9
1985 3
1986 4
1987 7
1988 7
1989 9
1990 5
1991 4
1992 8
1993 10
1994 6
1995 10
1996 10
1997 13
1998 10
1999 12
2000 12
2001 17
2002 16
2003 21
2004 37
2005 60
2006 64
2007 84
2008 92
2009 100
2010 124
2011 124
2012 146
2013 134
2014 157
2015 207
2016 200
2017 183
2018 183
2019 186
2020 186
2021 216
2022 211
2023 179
2024 58

Text availability

Article attribute

Article type

Publication date

Search Results

2,757 results

Results by year

Filters applied: . Clear all
Page 1
Photocoagulation for retinal vein occlusion.
Hayreh SS. Hayreh SS. Prog Retin Eye Res. 2021 Nov;85:100964. doi: 10.1016/j.preteyeres.2021.100964. Epub 2021 Mar 11. Prog Retin Eye Res. 2021. PMID: 33713810 Review.
The role of photocoagulation in retinal vein occlusion (RVO) has been studied since 1974. The most serious complications of central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) are: (i) visua …
The role of photocoagulation in retinal vein occlusion (RVO) has been studied since 1974. The most serious complication …
Anatomic Biomarkers of Macular Edema Associated with Retinal Vein Occlusion.
Ciulla TA, Kapik B, Hu A, Harris A, Ip MS, Blodi B. Ciulla TA, et al. Ophthalmol Retina. 2022 Dec;6(12):1206-1220. doi: 10.1016/j.oret.2022.06.016. Epub 2022 Jun 30. Ophthalmol Retina. 2022. PMID: 35781069 Free PMC article.
PURPOSE: To assess the relationship between best-corrected visual acuity (BCVA) and anatomic features in patients with macular edema (ME) related to retinal vein occlusion (RVO). DESIGN: Post hoc analysis of 3 clinical trials, which included ver …
PURPOSE: To assess the relationship between best-corrected visual acuity (BCVA) and anatomic features in patients with macular ede
Mechanisms of vision loss in eyes with macular edema associated with retinal vein occlusion.
Iijima H. Iijima H. Jpn J Ophthalmol. 2018 May;62(3):265-273. doi: 10.1007/s10384-018-0586-5. Epub 2018 Mar 23. Jpn J Ophthalmol. 2018. PMID: 29572577 Review.
Anti-vascular endothelial growth factor agents reduce macular edema and improve vision in eyes with macular edema associated with retinal vein occlusion (RVO), including branch RVO (BRVO) and central RVO. However, not all eyes with …
Anti-vascular endothelial growth factor agents reduce macular edema and improve vision in eyes with macular edema
The Impact of Residual Retinal Fluid Following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review.
Patil NS, Mihalache A, Dhoot AS, Popovic MM, Muni RH, Kertes PJ. Patil NS, et al. Ophthalmic Surg Lasers Imaging Retina. 2023 Jan;54(1):50-58. doi: 10.3928/23258160-20221122-01. Epub 2023 Jan 1. Ophthalmic Surg Lasers Imaging Retina. 2023. PMID: 36626212 Review.
The association between residual retinal fluid and visual acuity for diabetic macular edema (DME) and macular edema (ME) secondary to retinal vein occlusion (RVO) is not well established. ...Two observational studies on ME s …
The association between residual retinal fluid and visual acuity for diabetic macular edema (DME) and macular
Management of macular oedema due to retinal vein occlusion: An evidence-based systematic review and meta-analysis.
Cornish EE, Zagora SL, Spooner K, Fraser-Bell S. Cornish EE, et al. Clin Exp Ophthalmol. 2023 May-Jun;51(4):313-338. doi: 10.1111/ceo.14225. Epub 2023 Apr 14. Clin Exp Ophthalmol. 2023. PMID: 37060158
BACKGROUND: Central retinal vein occlusion and branch retinal vein occlusion are common causes of visual loss due to associated macular oedema. The aim of this review was to assess the effectiveness of interventions improving visio …
BACKGROUND: Central retinal vein occlusion and branch retinal vein occlusion are common causes of …
[Management of macular edema secondary to retinal vein occlusion].
Girmens JF, Glacet-Bernard A, Kodjikian L, Nghiêm-Buffet S, Massé H, Fourmaux E, Wolff B, Roquet W, Gaucher D, Baillif S, Tadayoni R. Girmens JF, et al. J Fr Ophtalmol. 2015 Mar;38(3):253-63. doi: 10.1016/j.jfo.2014.10.003. Epub 2015 Feb 13. J Fr Ophtalmol. 2015. PMID: 25683131 Review. French.
BACKGROUND: In recent years, intravitreal injections have added to the treatment modalities available for macular edema (ME) secondary to retinal vein occlusion (RVO). This article aims to provide an update regarding the management of ME seconda …
BACKGROUND: In recent years, intravitreal injections have added to the treatment modalities available for macular edema (ME) s …
[Long-term outcomes of anti-VEGF therapy for macular edema in retinal vein occlusion].
Drozdova EA. Drozdova EA. Vestn Oftalmol. 2022;138(3):140-148. doi: 10.17116/oftalma2022138031140. Vestn Oftalmol. 2022. PMID: 35801893 Review. Russian.
Antiangiogenic therapy (anti-VEGF) is the standard in the treatment of many retinal vascular diseases, including macular edema associated with retinal vein occlusion (RVO). ...
Antiangiogenic therapy (anti-VEGF) is the standard in the treatment of many retinal vascular diseases, including macular ed
CENTRAL RETINAL VEIN OCCLUSION WITH SEVERE MACULAR EDEMA IN EARLY PREGNANCY.
Pokroy R, Raskin E, Masarwa D. Pokroy R, et al. Retin Cases Brief Rep. 2022 Sep 1;16(5):547-549. doi: 10.1097/ICB.0000000000001063. Retin Cases Brief Rep. 2022. PMID: 33017380
PURPOSE: To report the clinical course and treatment outcomes of a patient with central retinal vein occlusion with severe macular edema in early pregnancy. ...Her baby was healthy. CONCLUSION: Although pregnancy seems to aggravate central re
PURPOSE: To report the clinical course and treatment outcomes of a patient with central retinal vein occlusion with sev …
Intravitreal Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusion.
Parajuli A, Joshi P, Subedi P, Pradhan C. Parajuli A, et al. Nepal J Ophthalmol. 2020 Jul;12(24):281-289. doi: 10.3126/nepjoph.v12i2.28761. Nepal J Ophthalmol. 2020. PMID: 33978623
INTRODUCTION: The most common cause of vision loss in cases of Retinal vein occlusion (RVO) is due to macular edema. This study was conducted to examine the effect of intravitreal bevacizumab (IVB) in the treatment of macular edema
INTRODUCTION: The most common cause of vision loss in cases of Retinal vein occlusion (RVO) is due to macular
Macular edema secondary to retinal vein occlusion in a real-life setting: a multicenter, nationwide, 3-year follow-up study.
Costa JV, Moura-Coelho N, Abreu AC, Neves P, Ornelas M, Furtado MJ. Costa JV, et al. Graefes Arch Clin Exp Ophthalmol. 2021 Feb;259(2):343-350. doi: 10.1007/s00417-020-04932-0. Epub 2020 Sep 23. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 32965652
PURPOSE: To evaluate the presence of macular edema secondary to retinal vein occlusion (RVO)-both central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO)-3 years after diagnosis in …
PURPOSE: To evaluate the presence of macular edema secondary to retinal vein occlusion (RVO)-both central …
2,757 results